Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumoniaLuzelena Caro, Elizabeth G. Rhee, Kajal Larson et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 67
Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal ClearanceDavid P. Nicolau, Matthew L. Rizk, Jan J. De Waele et al.|International Journal of Antimicrobial Agents|2021Cited by 34